Pediatric acute respiratory distress syndrome

disease
On this page

Also known as PARDS

Summary

Pediatric acute respiratory distress syndrome (MONDO:0100131) is a disease and 8 clinical trials. Top therapeutic interventions include desflurane. A subtype of acute respiratory distress syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Phenotypes (HPO): 16
  • Clinical trials: 8

Clinical features

Signs & symptoms

Clinical features (HPO)

16 HPO clinical features (Orphanet curated; top 16 by frequency):

HPO IDTermFrequency
HP:0012418HypoxemiaVery frequent (80-99%)
HP:0000765Abnormal thorax morphologyFrequent (30-79%)
HP:0000961CyanosisFrequent (30-79%)
HP:0001622Premature birthFrequent (30-79%)
HP:0002789TachypneaFrequent (30-79%)
HP:0002878Respiratory failureFrequent (30-79%)
HP:0030863Nasal flaringFrequent (30-79%)
HP:0100598Pulmonary edemaFrequent (30-79%)
HP:0100750AtelectasisFrequent (30-79%)
HP:0001649TachycardiaOccasional (5-29%)
HP:0001662BradycardiaOccasional (5-29%)
HP:0001695Cardiac arrestOccasional (5-29%)
HP:0002090PneumoniaOccasional (5-29%)
HP:0002615HypotensionOccasional (5-29%)
HP:0011947Respiratory tract infectionOccasional (5-29%)
HP:0100806SepsisVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical namepediatric acute respiratory distress syndrome
Mondo IDMONDO:0100131
Orphanet685082
UMLSC6012346
MedGen1876564
GARD0027370
Is cancer (heuristic)no

Also known as: PARDS

Disease family

This is a subtype of acute respiratory distress syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › acute diseaseacute respiratory failureacute respiratory distress syndromepediatric acute respiratory distress syndrome

Related subtypes (1): adult acute respiratory distress syndrome

Subtypes (1): newborn respiratory distress syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 8.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified6
PHASE41
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05783518PHASE4UNKNOWNEffect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
NCT07123961PHASE2RECRUITINGPediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
NCT06051292Not specifiedRECRUITINGDecremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
NCT06369584Not specifiedRECRUITINGProne Position During ECMO in Pediatric Patients With Severe ARDS
NCT06684119Not specifiedRECRUITINGPediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)
NCT06836050Not specifiedRECRUITINGIPV and Lung Compliance in Invasively Ventilated Children
NCT03585582Not specifiedUNKNOWNPost-discharge Outcomes of Pediatric Acute Respiratory Distress Syndrome
NCT06586411Not specifiedCOMPLETEDComparison of Oxygenation Index and Oxygen Stretch Index

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
DESFLURANE41